GSK4382276 / GSK, CureVac - LARVOL DELTA

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1/2 | N=1268 | Completed | Sponsor: GlaxoSmithKline | Phase classification: P1 ➔ P1/2

Phase classification • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=1268 | Completed | Sponsor: GlaxoSmithKline | Active, not recruiting ➔ Completed | Phase classification: P1/2 ➔ P1

Phase classification • Trial completion • Infectious Disease • Influenza • Respiratory Diseases

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P2 | N=838 | Active, not recruiting | Sponsor: GlaxoSmithKline | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P2 | N=838 | Recruiting | Sponsor: GlaxoSmithKline | Active, not recruiting ➔ Recruiting | N=510 ➔ 838 | Trial completion date: Dec 2024 ➔ Jun 2025 | Trial primary completion date: Jul 2024 ➔ Dec 2024

Enrollment change • Enrollment open • Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P2 | N=510 | Active, not recruiting | Sponsor: GlaxoSmithKline | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P2 | N=500 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Influenza • Respiratory Diseases

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P2 | N=500 | Not yet recruiting | Sponsor: GlaxoSmithKline

New P2 trial • Infectious Disease • Influenza • Respiratory Diseases

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=324 | Completed | Sponsor: GlaxoSmithKline | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1/2 | N=1256 | Active, not recruiting | Sponsor: GlaxoSmithKline | Phase classification: P1 ➔ P1/2

Phase classification • Infectious Disease • Influenza • Respiratory Diseases

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=324 | Active, not recruiting | Sponsor: GlaxoSmithKline | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=1256 | Active, not recruiting | Sponsor: GlaxoSmithKline | Recruiting ➔ Active, not recruiting | Phase classification: P1/2 ➔ P1

Enrollment closed • Phase classification • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1/2 | N=1253 | Recruiting | Sponsor: GlaxoSmithKline | Active, not recruiting ➔ Recruiting | N=293 ➔ 1253

Enrollment change • Enrollment open • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1/2 | N=293 | Active, not recruiting | Sponsor: GlaxoSmithKline | Recruiting ➔ Active, not recruiting | N=1512 ➔ 293

Enrollment change • Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1/2 | N=1512 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Influenza • Respiratory Diseases

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=336 | Recruiting | Sponsor: GlaxoSmithKline | Active, not recruiting ➔ Recruiting | N=198 ➔ 336 | Trial completion date: Jun 2023 ➔ Jan 2024 | Trial primary completion date: Jun 2023 ➔ Jan 2024

Enrollment change • Enrollment open • Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1/2 | N=1512 | Not yet recruiting | Sponsor: GlaxoSmithKline

New P1/2 trial • Infectious Disease • Influenza • Respiratory Diseases

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=198 | Active, not recruiting | Sponsor: GlaxoSmithKline | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=168 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Respiratory Diseases

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (clinicaltrials.gov) - P1 | N=168 | Not yet recruiting | Sponsor: GlaxoSmithKline

New P1 trial • Infectious Disease • Respiratory Diseases